The DOI matches its Crossref record.
Estimated number of prevalent cases of metastatic bone disease in the US adult population
Open accessAbstract
BACKGROUND: The prevalence of metastatic bone disease in the US population is not well understood. We sought to estimate the current number of US adults with metastatic bone disease using two large administrative data sets. METHODS: Prevalence was estimated from a commercially insured cohort (ages 18-64 years, MarketScan database) and from a fee-for-service Medicare cohort (ages ≥65 years, Medicare 5% database) with coverage on December 31, 2008, representing approximately two-thirds of the US population in each age group. We searched for claims-based evidence of metastatic bone disease from January 1, 2004, using a combination of relevant diagnosis and treatment codes. The number of cases in the US adult population was extrapolated from age- and sex-specific prevalence estimated in these cohorts. Results are presented for all cancers combined and separately for primary breast, prostate, and lung cancer. RESULTS: In the commercially insured cohort (mean age = 42.3 years [SD = 13.1]), we identified 9505 patients (0.052%) with metastatic bone disease. Breast cancer was the most common primary tumor type (n = 4041). In the Medicare cohort (mean age = 75.6 years [SD = 7.8]), we identified 6427 (0.495%) patients with metastatic bone disease. Breast (n = 1798) and prostate (n = 1862) cancers were the most common primary tumor types. We estimate that 279,679 (95% confidence interval: 274,579-284,780) US adults alive on December 31, 2008, had evidence of metastatic bone disease in the previous 5 years. Breast, prostate, and lung cancers accounted for 68% of these cases. CONCLUSION: Our findings suggest that approximately 280,000 US adults were living with metastatic bone disease on December 31, 2008. This likely underestimates the true frequency; not all cases of metastatic bone disease are diagnosed, and some diagnosed cases might lack documentation in claims data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Maher, C., Underwood, M., & Buchbinder, R. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30970-9 · Cited by 2,535
Hernandez, R. K., Wade, S. W., Reich, A., Pirolli, M., Liede, A., & Lyman, G. H. (2018) · BMC Cancer · doi:10.1186/s12885-017-3922-0 · Cited by 383
Spratt, D. E., Beeler, W. H., de Moraes, F. Y., Rhines, L. D., Gemmete, J. J., Chaudhary, N., Shultz, D. B., Smith, S. R., Berlin, A., Dahele, M., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30612-5 · Cited by 363
Metadata
- Authors
- Arneson, T. J., Li, S., Peng, Y., Weinhandl, E. D., Blaes, A., Cetin, K., Chia, V. M., Stryker, S., Pinzone, J. J., & Acquavella, J.
- Venue
- Clinical Epidemiology
- Publisher
- Informa UK Limited
- Published
- 2012-04
- Volume
- 4
- Pages
- 87
- ISSN
- 1179-1349 (ISSN-L)
- OpenAlex
- W2057374944
- Cited by
- 250
- References
- 0
- FWCI
- 4.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estimated number of prevalent cases of metastatic bone disease in the US adult population. https://app.cochat.ai/papers/10.2147/clep.s28339
- The paper
- Arneson, T. J., Li, S., Peng, Y., Weinhandl, E. D., Blaes, A., Cetin, K., Chia, V. M., Stryker, S., Pinzone, J. J., & Acquavella, J. (2012). Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clinical Epidemiology. https://doi.org/10.2147/clep.s28339
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.